Publications

5532 Results

A new predictive PCR assay for detecting normal and malignant tissue thymidylate synthase (T.S.) gene expression in patients with 5-fluorouracil (5-FU) sensitive and resistant colorectal cancer.

Authors
E Tian;KR Reddy;A Livingstone;B Ardalan
Journal / Conference
AACR 34:387(#2310)
Year
1993

One versus 2 years of CMFVP adjuvant chemotherapy in axillary node-positive and estrogen receptor-negative patients: A Southwest Oncology Group study.

Authors
SE Rivkin;S Green;B Metch;WR Jewell;JJ Costanzi;SJ Altman;JP Minton;RM O'Bryan;CK Osborne
Journal / Conference
JCO 11(9):1710-1716
Year
1993
Research Committee(s)
Breast
Study Number(s)
SWOG-7827

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1-4 mm): Results of multi-institutional randomized surgical trial.

Authors
CM Balch;MM Urist;CP Karakousis;TJ Smith;WJ Temple;K Drzewiecki;WR Jewell;AA Bartolucci;MC Mihm Jr;R Barnhill;H Wanebo
Journal / Conference
Annals of Surgery 218(3):262-269
Year
1993
Research Committee(s)
Melanoma
Study Number(s)
SWOG-8393 (INT-0013)

Cyclophosphamide, methotrexate and 5-fluorouracil in the treatment of metastatic prostate cancer: A Southwest Oncology Group study.

Authors
AJ Wozniak;BA Blumenstein;ED Crawford;M Boileau;SE Rivkin;WS Fletcher
Journal / Conference
Cancer 71(12):3975-3978
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8421

Is a surgical resection leaving positive margins of benefit to the patient with locally advanced squamous cell carcinoma of the head and neck: A comparative study using the Intergroup study 0034 and the Radiation Therapy Oncology Group head and neck database.

Authors
GE Laramore;CB Scott;DE Schuller;RE Haselow;TJ Ervin;R Wheeler;M Al-Sarraf;RA Gahbauer;JR Jacobs;JG Schwade;BH Campbell
Journal / Conference
International J of Radiation Oncology Biology Physics 27:1011-1016
Year
1993
Research Committee(s)
Head and Neck
Study Number(s)
SWOG-8590 (INT-0034)

Predictors of survival following relapse or progression of small cell lung cancer: Southwest Oncology Group study #8605 and an analysis of the recurrent disease data base.

Authors
KS Albain;JJ Crowley;L Hutchins;D Gandara;RM O'Bryan;DD Von Hoff;B Griffin;RB Livingston
Journal / Conference
Cancer 72(4):1184-1191
Year
1993
Research Committee(s)
Lung
Study Number(s)
SWOG-8009, SWOG-8215, SWOG-8605

VM-26 in gastric cancer: A Southwest Oncology Group study.

Authors
JL Berenberg;C Tangen;JS Macdonald;B Barlogie;LR Laufman
Journal / Conference
Investigational New Drugs 11:333-334
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8614

Phase II trial of amonafide in advanced pancreas cancer: A Southwest Oncology Group study.

Authors
CG Leichman;C Tangen;JS Macdonald;T Leimert;TR Fleming
Journal / Conference
IND 11:219-221
Year
1993
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-8720

A randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good risk germ cell tumors: A multi-institutional study.

Authors
DF Bajorin;MF Sarosdy;DG Pfister;M Mazumdar;RJ Motzer;HI Scher;NL Geller;WR Fair;H Herr;P Sogani;J Sheinfeld;P Russo;V Vlamis;R Carey;NJ Vogelzang;ED Crawford;GJ Bosi
Journal / Conference
JCO 11(4):598-606
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8789

Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma: A Southwest Oncology Group study.

Authors
ME Marshall;MK Wolf;ED Crawford;S Taylor;B Blumenstein;R Flanigan;FJ Meyers;HE Hynes;B Barlogie;M Eisenberger
Journal / Conference
IND 11:207-209
Year
1993
Research Committee(s)
Genitourinary
Study Number(s)
SWOG-8802